Centre Hospitalier Metropole Savoie
Chambéry, Savoie, 73011, France
NCT Number: NCT06121960
The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
The main question:
Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chambéry, Savoie, 73011, France
Primary objective : Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance judgment criteria:
Significant variations in:
PEF PEF25 PEF50 PEF75 FVC Inspiratory capacity, SpO2 Respiratory rate before, during, or after the self-induced cognitive trance state Evolution of the feeling of self-efficacy, assessed by questionnaire
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inclusion visit:
Performing spirometry.
Visit 2 (in the month following the inclusion visit):
Induction of a self-induced cognitive trance by the participant; performance of spirometry before, during the trance then 8 minutes after the end of the trance Actimetry during trance
Time frame: 3 month
variation of forced exhaled volume in one second between pre and post phase of cognitive transe
Time frame: 3 month
variation of PEF between pre, per and post phase of cognitive transe
Time frame: 3 month
variation of DEM25/50/75 between pre, per and post phase of cognitive transe
Time frame: 3 month
variation of inspiratory capacity between pre, per and post phase of cognitive transe
Time frame: 3 month
variation of respiratory rate between pre, per and post phase of cognitive transe
Time frame: 3 month
variation of SpO2 between pre, per and post phase of cognitive transe
Time frame: 3 month
variation of FVC between pre, per and post phase of cognitive transe
Centre Hospitalier Metropole Savoie
Other
Acronym: SPIROTRANSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737587
Behavior, Pathologic Processes
Iğdır, Turkey (Türkiye)
View Trial DetailsNCT07677501
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT07041593
Balance, Brain Damage, Chronic
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07528222
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Taipei, Taiwan
View Trial Details